Search Results - Tim Beaumont
- Showing 1 - 11 results of 11
-
1
-
2
Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors by Rachel Thijssen, Erik Slinger, Katinka Weller, Christian R. Geest, Tim Beaumont, Marinus H.J. van Oers, Arnon P. Kater, Eric Eldering
Published in Haematologica (2015-08-01)Get full text
Article -
3
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns by Ana Chumbe, Marloes Grobben, Joan Capella-Pujol, Sylvie M. Koekkoek, Ian Zon, Stefan Slamanig, Sabrina J. Merat, Tim Beaumont, Kwinten Sliepen, Janke Schinkel, Marit J. van Gils
Published in Virus Research (2024-03-01)Get full text
Article -
4
Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain by Denise Guerra, Laura Radić, Mitch Brinkkemper, Meliawati Poniman, Lara van der Maas, Jonathan L. Torres, Andrew B. Ward, Kwinten Sliepen, Janke Schinkel, Rogier W. Sanders, Marit J. van Gils, Tim Beaumont
Published in Human Vaccines & Immunotherapeutics (2024-12-01)Get full text
Article -
5
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein. by Morgan S A Gilman, Syed M Moin, Vicente Mas, Man Chen, Nita K Patel, Kari Kramer, Qing Zhu, Stephanie C Kabeche, Azad Kumar, Concepción Palomo, Tim Beaumont, Ulrich Baxa, Nancy D Ulbrandt, José A Melero, Barney S Graham, Jason S McLellan
Published in PLoS Pathogens (2015-07-01)Get full text
Article -
6
Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance. by Sabrina J Merat, Richard Molenkamp, Koen Wagner, Sylvie M Koekkoek, Dorien van de Berg, Etsuko Yasuda, Martino Böhne, Yvonne B Claassen, Bart P Grady, Maria Prins, Arjen Q Bakker, Menno D de Jong, Hergen Spits, Janke Schinkel, Tim Beaumont
Published in PLoS ONE (2016-01-01)Get full text
Article -
7
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses. by Karlijn van der Straten, Denise Guerra, Gius Kerster, Mathieu Claireaux, Marloes Grobben, Angela I Schriek, Anders Boyd, Jacqueline van Rijswijk, Khadija Tejjani, Dirk Eggink, Tim Beaumont, Steven W de Taeye, Godelieve J de Bree, Rogier W Sanders, Marit J van Gils
Published in PLoS Pathogens (2024-08-01)Get full text
Article -
8
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses by Philip J.M. Brouwer, Hailee R. Perrett, Tim Beaumont, Haye Nijhuis, Sabine Kruijer, Judith A. Burger, Ilja Bontjer, Wen-Hsin Lee, James A. Ferguson, Martin Schauflinger, Helena Müller-Kräuter, Rogier W. Sanders, Thomas Strecker, Marit J. van Gils, Andrew B. Ward
Published in Cell Reports (2024-09-01)Get full text
Article -
9
Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. by Pablo D Becker, Nicolas Legrand, Caroline M M van Geelen, Miriam Noerder, Nicholas D Huntington, Annick Lim, Etsuko Yasuda, Sean A Diehl, Ferenc A Scheeren, Michael Ott, Kees Weijer, Heiner Wedemeyer, James P Di Santo, Tim Beaumont, Carlos A Guzman, Hergen Spits
Published in PLoS ONE (2010-10-01)Get full text
Article -
10
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual by Denise Guerra, Tim Beaumont, Laura Radić, Gius Kerster, Karlijn van der Straten, Meng Yuan, Jonathan L. Torres, Wen-Hsin Lee, Hejun Liu, Meliawati Poniman, Ilja Bontjer, Judith A. Burger, Mathieu Claireaux, Tom G. Caniels, Jonne L. Snitselaar, Tom P.L. Bijl, Sabine Kruijer, Gabriel Ozorowski, David Gideonse, Kwinten Sliepen, Andrew B. Ward, Dirk Eggink, Godelieve J. de Bree, Ian A. Wilson, Rogier W. Sanders, Marit J. van Gils
Published in iScience (2023-10-01)Get full text
Article -
11
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort studyResearch in context by Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Nynke Rots, Josine van Beek, Mirjam H.M. Heemskerk, Kazimierz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof, Iris M.J. Kant, Thecla Graas, Belle Toussaint, Sterre de Jong, Shahan Darwesh, Sandjiv S. Mahes, Dora Kamminga, Matthijs Koelewijn, Gino Faber, Guus Beaumont, Marije D. Engel, R. Cheyenne N. Pierie, Suzanne R. Janssen, Gino Faber, Edith van Dijkman, Jarom Heijmans, Yara Y. Witte, Rogers A. Nahui Palomino, Said Z. Omar, Sonja Zweegman, Arnon P. Kater, Caya van den Vegt, Ilonka Arends-Halbesma, Emma de Pater, Margriet J. Dijkstra, Nynke Y. Rots, Esther Siteur-van Rijnstra, Dennis M. de Rooij, Rogier W. Sanders, Meliawati Poniman, Wouter Olijhoek, Jacqueline van Rijswijk, Tim Beaumont, Lusia Çetinel, Louis Schellekens, Yvonne M. den Hartogh, Jacqueline Cloos, Suzanne S. Weijers, Saïda Tonouh-Aajoud, Selime Avci, Elianne Roelandse-Koop, Willem A. Dik
Published in EClinicalMedicine (2023-07-01)Get full text
Article
